92 related articles for article (PubMed ID: 17688486)
1. Prospective accuracy for longitudinal markers.
Zheng Y; Heagerty PJ
Biometrics; 2007 Jun; 63(2):332-41. PubMed ID: 17688486
[TBL] [Abstract][Full Text] [Related]
2. Semiparametric estimation of time-dependent ROC curves for longitudinal marker data.
Zheng Y; Heagerty PJ
Biostatistics; 2004 Oct; 5(4):615-32. PubMed ID: 15475423
[TBL] [Abstract][Full Text] [Related]
3. The sensitivity and specificity of markers for event times.
Cai T; Pepe MS; Zheng Y; Lumley T; Jenny NS
Biostatistics; 2006 Apr; 7(2):182-97. PubMed ID: 16079162
[TBL] [Abstract][Full Text] [Related]
4. Partly conditional survival models for longitudinal data.
Zheng Y; Heagerty PJ
Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
[TBL] [Abstract][Full Text] [Related]
5. Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data.
Rizopoulos D
Biometrics; 2011 Sep; 67(3):819-29. PubMed ID: 21306352
[TBL] [Abstract][Full Text] [Related]
6. Estimation for the optimal combination of markers without modeling the censoring distribution.
Chiang CT; Huang SY
Biometrics; 2009 Mar; 65(1):152-8. PubMed ID: 18422791
[TBL] [Abstract][Full Text] [Related]
7. Estimation of incidence of HIV infection using cross-sectional marker surveys.
Statten GA; Longini IM
Biometrics; 1994 Sep; 50(3):675-88. PubMed ID: 7981394
[TBL] [Abstract][Full Text] [Related]
8. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers.
Zheng Y; Cai T; Feng Z
Biometrics; 2006 Mar; 62(1):279-87. PubMed ID: 16542256
[TBL] [Abstract][Full Text] [Related]
9. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
10. ROC curves with multiple marker measurements.
Murtaugh PA
Biometrics; 1995 Dec; 51(4):1514-22. PubMed ID: 8589236
[TBL] [Abstract][Full Text] [Related]
11. The analysis of placement values for evaluating discriminatory measures.
Pepe MS; Cai T
Biometrics; 2004 Jun; 60(2):528-35. PubMed ID: 15180681
[TBL] [Abstract][Full Text] [Related]
12. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
Seminari E; De Silvestri A; Boschi A; Tinelli C
AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
[TBL] [Abstract][Full Text] [Related]
13. Robust combination of multiple diagnostic tests for classifying censored event times.
Cai T; Cheng S
Biostatistics; 2008 Apr; 9(2):216-33. PubMed ID: 18056687
[TBL] [Abstract][Full Text] [Related]
14. ROC graphs for assessing the ability of a diagnostic marker to detect three disease classes with an umbrella ordering.
Nakas CT; Alonzo TA
Biometrics; 2007 Jun; 63(2):603-9. PubMed ID: 17688513
[TBL] [Abstract][Full Text] [Related]
15. Attributable risk function in the proportional hazards model for censored time-to-event.
Chen YQ; Hu C; Wang Y
Biostatistics; 2006 Oct; 7(4):515-29. PubMed ID: 16478758
[TBL] [Abstract][Full Text] [Related]
16. A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort.
Taffé P; May M;
Stat Med; 2008 Oct; 27(23):4835-53. PubMed ID: 18444229
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
18. Predicting renal graft failure using multivariate longitudinal profiles.
Fieuws S; Verbeke G; Maes B; Vanrenterghem Y
Biostatistics; 2008 Jul; 9(3):419-31. PubMed ID: 18056686
[TBL] [Abstract][Full Text] [Related]
19. Joint inference for nonlinear mixed-effects models and time to event at the presence of missing data.
Wu L; Hu XJ; Wu H
Biostatistics; 2008 Apr; 9(2):308-20. PubMed ID: 17728318
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
